|
RS52392B
(sr)
*
|
2002-02-14 |
2013-02-28 |
Pharmacia Corporation |
Supstituisani piridinoni kao modulatori p38 map kinaze
|
|
US7456222B2
(en)
*
|
2002-05-17 |
2008-11-25 |
Sequella, Inc. |
Anti tubercular drug: compositions and methods
|
|
CN101404986B
(zh)
*
|
2002-05-17 |
2011-09-28 |
赛奎拉公司 |
用于诊断和治疗感染性疾病的组合物和制药方法
|
|
US20040033986A1
(en)
*
|
2002-05-17 |
2004-02-19 |
Protopopova Marina Nikolaevna |
Anti tubercular drug: compositions and methods
|
|
EP1405849A1
(en)
*
|
2002-10-04 |
2004-04-07 |
Corning Incorporated |
Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom
|
|
CL2004002050A1
(es)
*
|
2003-08-13 |
2005-06-03 |
Pharmacia Corp Sa Organizada B |
Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
|
|
EP1670314A4
(en)
*
|
2003-09-05 |
2009-02-25 |
Sequella Inc |
METHODS AND COMPOSITIONS INCLUDE DIAMINE AS A NEW THERAPEUTIC FOR TUBERCULOSIS
|
|
JP4614884B2
(ja)
*
|
2003-11-14 |
2011-01-19 |
シャンハイ ゲノミックス インク |
ピリドンの誘導体とその使用
|
|
CA2546353A1
(en)
*
|
2003-11-19 |
2005-06-09 |
Array Biopharma Inc. |
Bicyclic inhibitors of mek and methods of use thereof
|
|
BRPI0418078A8
(pt)
|
2003-12-23 |
2018-01-02 |
Astex Therapeutics Ltd |
composto ou um seu sal, solvato, tautômero ou n-óxido, uso de um composto, métodos para a profilaxia ou tratamento de um estado ou condição doentia mediada pela proteína quinase b e mediada pela proteína quinase a, para tratar uma doença ou condição, para inibir uma proteína quinase b e uma proteína quinase a, para modular um processo celular, para tratar um distúrbio imune em um mamífero e para induzir apoptose em uma célula cancerosa, composição farmacêutica, e, processo para a preparação de um composto
|
|
WO2005085200A1
(ja)
*
|
2004-03-05 |
2005-09-15 |
Banyu Pharmaceutical Co., Ltd. |
ピリドン誘導体
|
|
JPWO2005105743A1
(ja)
*
|
2004-04-28 |
2008-03-13 |
小野薬品工業株式会社 |
含窒素複素環化合物およびその医薬用途
|
|
TWI355380B
(en)
*
|
2004-05-27 |
2012-01-01 |
Nihon Nohyaku Co Ltd |
Substituted pyrazinecarboxanilide derivatives or s
|
|
JP4853759B2
(ja)
*
|
2004-05-27 |
2012-01-11 |
日本農薬株式会社 |
置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法
|
|
PL1778686T3
(pl)
|
2004-08-12 |
2009-04-30 |
Pfizer |
Pochodne triazolopirydynylosulfanylowe jako inhibitory kinazy MAP P38
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
WO2006040666A1
(en)
*
|
2004-10-13 |
2006-04-20 |
Pharmacia & Upjohn Company Llc |
Substituted n-alkylpyrimidinones
|
|
US7713998B2
(en)
|
2004-11-10 |
2010-05-11 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenous heterocyclic compound and pharmaceutical use thereof
|
|
WO2006056427A1
(en)
*
|
2004-11-24 |
2006-06-01 |
Laboratoires Serono S.A. |
Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders
|
|
MX2007007599A
(es)
|
2004-12-21 |
2007-12-07 |
Serono Lab |
Dervivados ciclicos de sulfonilamino y uso de los mismos.
|
|
PL1844032T3
(pl)
|
2005-01-31 |
2011-09-30 |
Merck Serono Sa |
Pochodne N-hydroksyamidu i ich zastosowanie
|
|
ES2524922T3
(es)
|
2005-05-10 |
2014-12-15 |
Intermune, Inc. |
Derivados de piridona para modular el sistema de proteína cinasa activada por estrés
|
|
EP1902032A1
(en)
|
2005-06-22 |
2008-03-26 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
JP5345842B2
(ja)
|
2005-06-23 |
2013-11-20 |
アステックス・セラピューティクス・リミテッド |
プロテインキナーゼモジュレーターとしてのピラゾール誘導体を含む医薬組み合わせ
|
|
WO2007006591A2
(fr)
*
|
2005-07-13 |
2007-01-18 |
Bayer Cropscience Sa |
Dihalogenation d'hydroxipyridones n,o-disubstituees et leurs utilisations
|
|
JPWO2007018248A1
(ja)
|
2005-08-10 |
2009-02-19 |
萬有製薬株式会社 |
ピリドン化合物
|
|
EP1921065B1
(en)
|
2005-08-24 |
2010-10-20 |
Banyu Pharmaceutical Co., Ltd. |
Phenylpyridone derivative
|
|
JP2009506123A
(ja)
|
2005-08-29 |
2009-02-12 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
非受容体型チロシンキナーゼのｔｅｃファミリーの阻害剤として有用な３，５−二置換ピリド−２−オン
|
|
EP1919905B1
(en)
*
|
2005-08-29 |
2011-02-23 |
Vertex Pharmaceuticals Incorporated |
3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-recptor tyrosine kinases
|
|
WO2007027594A1
(en)
|
2005-08-29 |
2007-03-08 |
Vertex Pharmaceuticals Incorporated |
3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
|
|
JP2009507003A
(ja)
|
2005-09-01 |
2009-02-19 |
アレス トレーディング ソシエテ アノニム |
視神経炎の治療
|
|
WO2007029847A1
(ja)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
二環性芳香族置換ピリドン誘導体
|
|
US7973060B2
(en)
*
|
2005-10-13 |
2011-07-05 |
Crystalgenomics, Inc. |
Fab I inhibitor and process for preparing same
|
|
TWI417095B
(zh)
*
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
１，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
|
|
US7968711B2
(en)
|
2006-04-24 |
2011-06-28 |
Allergan, Inc. |
Abnormal cannabidiols as agents for lowering intraocular pressure
|
|
US7618966B2
(en)
|
2006-04-24 |
2009-11-17 |
Allergan, Inc. |
Abnormal Cannabidiols as agents for lowering intraocular pressure
|
|
US7718830B2
(en)
|
2006-04-24 |
2010-05-18 |
Allergan, Inc. |
Abnormal cannabidiols as agents for lowering intraocular pressure
|
|
UY30378A1
(es)
*
|
2006-06-02 |
2008-01-02 |
Janssen Pharmaceutica Nv |
Nuevos derivados de piridinona n-aril y n-heteroaril sustituidos para usar en enfermedades mediadas por mch-1
|
|
WO2007143597A2
(en)
*
|
2006-06-05 |
2007-12-13 |
Novartis Ag |
Organic compounds
|
|
ES2426780T3
(es)
*
|
2006-07-14 |
2013-10-25 |
Amgen Inc. |
Compuestos de piridona sustituidos con alquino y métodos de uso
|
|
KR20090047542A
(ko)
|
2006-08-25 |
2009-05-12 |
베링거 인겔하임 인터내셔날 게엠베하 |
Ｍｃｈ 길항 활성을 갖는 신규한 피리돈 유도체 및 당해 화합물을 포함하는 의약
|
|
WO2008041090A1
(en)
*
|
2006-10-06 |
2008-04-10 |
Pfizer Limited |
Malanin concentrating hormone receptor-1 antagonist pyridinones
|
|
TW200831485A
(en)
|
2006-12-11 |
2008-08-01 |
Boehringer Ingelheim Int |
New pyridazine derivatives with MCH antagonistic activity and medicaments comprising these compounds
|
|
AU2007331199A1
(en)
*
|
2006-12-13 |
2008-06-19 |
Pfizer Products Inc. |
Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1 (2H)-yl)-N,4-dimethylbenzamide
|
|
CA2673299C
(en)
*
|
2006-12-21 |
2016-04-12 |
Sloan-Kettering Institute For Cancer Research |
Pyridazinone compounds for the treatment of proliferative diseases
|
|
JP2010515745A
(ja)
*
|
2007-01-10 |
2010-05-13 |
アルバニー モレキュラー リサーチ， インコーポレイテッド |
５−フロピリジノン置換インダゾール
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
GB0704932D0
(en)
|
2007-03-14 |
2007-04-25 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
JP5587184B2
(ja)
|
2007-06-20 |
2014-09-10 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
繊維症阻害剤としての置換ｎ−アリールピリジノン
|
|
SI2170864T1
(sl)
*
|
2007-07-17 |
2012-04-30 |
Bristol Myers Squibb Co |
Piridon gpr119g proteinsko povezani receptorski antagonisti
|
|
US8722894B2
(en)
|
2007-09-14 |
2014-05-13 |
Janssen Pharmaceuticals, Inc. |
1,3-disubstituted-4-phenyl-1H-pyridin-2-ones
|
|
US8252937B2
(en)
|
2007-09-14 |
2012-08-28 |
Janssen Pharmaceuticals, Inc. |
1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
|
|
PL2203439T3
(pl)
|
2007-09-14 |
2011-06-30 |
Addex Pharmaceuticals Sa |
1',3'-dipodstawione-4-fenylo-3,4,5,6-tetrahydro-2H, 1'H-[1, 4']bipirydynylo-2'-ketony
|
|
KR101270122B1
(ko)
|
2007-11-01 |
2013-05-31 |
어큐셀라 인코포레이티드 |
안과 질환 및 장애를 치료하기 위한 아민 유도체 화합물
|
|
RU2492170C9
(ru)
|
2007-11-14 |
2013-12-27 |
Орто-Макнейл-Янссен Фармасьютикалз, Инк. |
Имидазо[1,2-а]пиридиновые производные и их применение в качестве положительных аллостерических модуляторов рецепторов mglur2
|
|
CN101952274A
(zh)
*
|
2007-11-20 |
2011-01-19 |
默沙东公司 |
非核苷逆转录酶抑制剂
|
|
US20090281054A1
(en)
*
|
2008-05-06 |
2009-11-12 |
Venkata Reddy |
Compositions and methods comprising capuramycin analogues
|
|
CA2726588C
(en)
|
2008-06-03 |
2019-04-16 |
Karl Kossen |
Compounds and methods for treating inflammatory and fibrotic disorders
|
|
JP5547194B2
(ja)
|
2008-09-02 |
2014-07-09 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド． |
代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体
|
|
KR101258331B1
(ko)
|
2008-09-11 |
2013-04-26 |
화이자 인코포레이티드 |
헤테로아릴 아미드 유도체 및 글루코키나제 활성화제로서의 그의 용도
|
|
RU2517181C2
(ru)
|
2008-10-16 |
2014-05-27 |
Орто-Макнейл-Янссен Фармасьютикалз, Инк. |
Производные индола и бензоморфолина в качестве модулятора метаботропных глутаматных рецепторов
|
|
WO2010060589A1
(en)
|
2008-11-28 |
2010-06-03 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
|
WO2010084428A1
(en)
|
2009-01-20 |
2010-07-29 |
Pfizer Inc. |
Substituted pyrazinone amides
|
|
MY151246A
(en)
|
2009-03-11 |
2014-04-30 |
Pfizer |
Benzofuranyl derivatives
|
|
MY153912A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
1, 2, 4,-triazolo[4,3-a[pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
CN102439008B
(zh)
|
2009-05-12 |
2015-04-29 |
杨森制药有限公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
EP2474533B1
(en)
|
2009-05-25 |
2015-02-25 |
Central South University |
Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2-(1h)pyridone compounds and salts thereof and their applications
|
|
WO2010135972A1
(zh)
|
2009-05-25 |
2010-12-02 |
中南大学 |
1-(取代芳基)-5-三氟甲基-2-（1h）吡啶酮化合物及其盐的制备方法及其用途
|
|
US20110021570A1
(en)
|
2009-07-23 |
2011-01-27 |
Nancy-Ellen Haynes |
Pyridone glucokinase activators
|
|
CN101973936B
(zh)
*
|
2010-09-28 |
2012-02-08 |
太原理工大学 |
一种吡啶酮衍生物的制备方法
|
|
CN103261195B
(zh)
|
2010-11-08 |
2015-09-02 |
杨森制药公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
|
PL2649069T3
(pl)
|
2010-11-08 |
2016-01-29 |
Janssen Pharmaceuticals Inc |
Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2
|
|
EP2661435B1
(en)
|
2010-11-08 |
2015-08-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
WO2012078673A1
(en)
|
2010-12-06 |
2012-06-14 |
Confluence Life Sciences, Inc. |
Substituted pyridine urea compounds
|
|
US8507499B2
(en)
|
2010-12-06 |
2013-08-13 |
Confluence Life Sciences, Inc. |
Substituted indole/indazole-pyrimidinyl compounds
|
|
US20120142709A1
(en)
|
2010-12-06 |
2012-06-07 |
Selness Shaun R |
Substituted pyridinone-pyridinyl compounds
|
|
US9359300B2
(en)
|
2010-12-06 |
2016-06-07 |
Confluence Life Sciences, Inc. |
Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
|
|
MA34963B1
(fr)
*
|
2011-03-07 |
2014-03-01 |
Pfizer |
Derives de fluoro-pyridinone utiles en tant qu'agents antibacteriens
|
|
JP2014507474A
(ja)
|
2011-03-08 |
2014-03-27 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
置換ｎ−アリールピリジノン
|
|
KR20140085437A
(ko)
|
2011-08-29 |
2014-07-07 |
피티씨 테라퓨틱스, 인크. |
항균 화합물 및 이의 사용 방법
|
|
BR112014004515A2
(pt)
*
|
2011-08-29 |
2017-03-28 |
Ptc Therapeutics Inc |
"compostos antibacterianos, seu uso, composição farmacêutica e combinação terapêutica que os compreende"
|
|
WO2013057101A1
(de)
|
2011-10-17 |
2013-04-25 |
Bayer Intellectual Property Gmbh |
Substituierte oxadiazolylpyridinone und - pyridazinone als hif - hemmer
|
|
US20130150426A1
(en)
|
2011-11-22 |
2013-06-13 |
Intermune, Inc. |
Methods of diagnosing and treating idiopathic pulmonary fibrosis
|
|
US9056110B2
(en)
|
2011-12-06 |
2015-06-16 |
Confluence Life Sciences, Inc. |
Substituted pyrimidinone-phenyl-pyrimidinyl compounds
|
|
RU2630677C2
(ru)
|
2011-12-21 |
2017-09-12 |
Оно Фармасьютикал Ко., Лтд. |
Соединения
|
|
EP2802571A1
(en)
*
|
2012-01-12 |
2014-11-19 |
Takeda Pharmaceutical Company Limited |
Benzimidazole derivatives as mch receptor antagonists
|
|
HUE053994T2
(hu)
|
2012-03-01 |
2021-08-30 |
Array Biopharma Inc |
Szerin/treonin kináz inhibitorok
|
|
CN103288719A
(zh)
*
|
2012-03-05 |
2013-09-11 |
苏州欧凯医药技术有限公司 |
非核甘艾滋病毒抑制物-吡啶酮类先导体的合成
|
|
JP5924984B2
(ja)
*
|
2012-03-06 |
2016-05-25 |
国立大学法人東京農工大学 |
トリフルオロメチルピリジノン化合物およびその製造方法
|
|
US9434695B2
(en)
|
2012-07-18 |
2016-09-06 |
Sunshine Lake Pharma Co., Ltd |
Nitrogenous heterocyclic derivatives and their application in drugs
|
|
ES2691643T3
(es)
|
2012-08-24 |
2018-11-28 |
Board Of Regents, The University Of Texas System |
Moduladores heterocíclicos de la actividad de HIF para el tratamiento de enfermedades
|
|
US20140073634A1
(en)
*
|
2012-08-24 |
2014-03-13 |
Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center |
Heterocyclic modulators of hif activity for treatment of disease
|
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
|
PL2931716T3
(pl)
|
2012-12-13 |
2017-04-28 |
Novartis Ag |
Pochodne pirydonu i ich zastosowanie w leczeniu gruźlicy
|
|
KR102295748B1
(ko)
|
2013-01-31 |
2021-09-01 |
버텍스 파마슈티칼스 인코포레이티드 |
나트륨 채널의 조절제로서의 피리돈 아미드
|
|
WO2014181213A1
(en)
|
2013-05-10 |
2014-11-13 |
Pfizer Inc. |
Crystalline form of (sa)-(-)-3-(3-bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1 (2h)-yl)-n,4-dimethylbenzamide
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
SMT202100117T1
(it)
|
2013-06-07 |
2021-05-07 |
Aclaris Therapeutics Inc |
Composti piridinone-piridinile sostituiti con metil/fluoro-piridinil-metossi e composti piridinone-piridinile sostituiti con fluoro-pirimidinil-metossi
|
|
EP3019487A1
(en)
|
2013-07-09 |
2016-05-18 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
LT3080134T
(lt)
|
2013-12-13 |
2018-11-12 |
Vertex Pharmaceuticals Incorporated |
Piridono amidų provaistai, naudotini kaip natrio kanalų moduliatoriai
|
|
HUE053734T2
(hu)
|
2014-01-21 |
2021-07-28 |
Janssen Pharmaceutica Nv |
2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait tartalmazó kombinációk és alkalmazásuk
|
|
KR20220049612A
(ko)
|
2014-01-21 |
2022-04-21 |
얀센 파마슈티카 엔.브이. |
대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
|
|
WO2015130790A2
(en)
|
2014-02-25 |
2015-09-03 |
Board Of Regents, University Of Texas System |
Salts of heterocyclic modulators of hif activity for treatment of disease
|
|
MX382781B
(es)
|
2014-04-02 |
2025-03-13 |
Intermune Inc |
Piridinonas anti-fibroticas.
|
|
CN106660962A
(zh)
*
|
2014-07-30 |
2017-05-10 |
Abac治疗法有限公司 |
用作选择性抗菌剂的含2‑吡啶酮部分的芳基酰肼
|
|
MX385021B
(es)
|
2014-12-10 |
2025-03-14 |
Ono Pharmaceutical Co |
Derivado de dihidroindolizinona.
|
|
WO2016196771A1
(en)
*
|
2015-06-03 |
2016-12-08 |
Bristol-Myers Squibb Company |
4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders
|
|
CN105153027A
(zh)
*
|
2015-07-21 |
2015-12-16 |
东华大学 |
一种3-氰基-4-羟基-2-吡啶酮类化合物及其制备和应用
|
|
CN106466318B
(zh)
*
|
2015-08-21 |
2019-01-01 |
中南大学 |
1-杂环取代苄基吡啶酮类化合物在制备治疗糖尿病肾病药物中的应用
|
|
WO2017151409A1
(en)
|
2016-02-29 |
2017-09-08 |
University Of Florida Research Foundation, Incorporated |
Chemotherapeutic methods
|
|
US11358977B2
(en)
|
2017-05-16 |
2022-06-14 |
Vertex Pharmaceuticals Incorporated |
Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
|
|
KR102236356B1
(ko)
|
2017-11-24 |
2021-04-05 |
주식회사 종근당 |
루푸스의 예방 또는 치료를 위한 조성물
|
|
WO2019157505A1
(en)
|
2018-02-12 |
2019-08-15 |
Vertex Pharmaceuticals Incorporated |
A method of treating pain
|
|
KR20190099952A
(ko)
*
|
2018-02-20 |
2019-08-28 |
주식회사 종근당 |
포도막염의 예방 또는 치료를 위한 조성물
|
|
US12351556B2
(en)
*
|
2019-10-04 |
2025-07-08 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Pyridin-2(1H)one derivatives, their preparation and their use for the treatment of pain
|
|
CA3164134A1
(en)
|
2019-12-06 |
2021-06-10 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
GB201918413D0
(en)
*
|
2019-12-13 |
2020-01-29 |
Z Factor Ltd |
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
|
|
BR112022019349A2
(pt)
|
2020-03-27 |
2022-11-16 |
Aclaris Therapeutics Inc |
Forma cristalina, composição farmacêutica, comprimido e método para isolar um composto
|
|
JP2021183587A
(ja)
|
2020-05-22 |
2021-12-02 |
武田薬品工業株式会社 |
複素環化合物
|
|
CN112552232B
(zh)
*
|
2020-12-16 |
2022-11-25 |
浙江工业大学 |
一种吡啶酮六位炔胺修饰衍生物及其制备方法与应用
|
|
JP2024506858A
(ja)
|
2021-02-02 |
2024-02-15 |
リミナル・バイオサイエンシーズ・リミテッド |
Ｇｐｒ８４アンタゴニストおよびその使用
|
|
WO2022212489A1
(en)
*
|
2021-03-31 |
2022-10-06 |
Xinthera, Inc. |
Mk2 inhibitors and uses thereof
|
|
SI4347031T1
(sl)
|
2021-06-04 |
2026-01-30 |
Vertex Pharmaceuticals Incorporated |
N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
|
|
AU2022307534B2
(en)
*
|
2021-07-09 |
2025-12-04 |
Xinthera, Inc. |
Pyridinone mk2 inhibitors and uses thereof
|
|
CN118510776A
(zh)
*
|
2022-01-14 |
2024-08-16 |
上海翰森生物医药科技有限公司 |
含五元环类衍生物、其制备方法和应用
|
|
WO2024022412A1
(zh)
*
|
2022-07-28 |
2024-02-01 |
深圳信立泰药业股份有限公司 |
一种式(i)所示的三联吡啶二酮化合物晶型及其制备方法与应用
|